Under hypoxic conditions, miR-182-5p directly inhibits Krueppel-Like Factor 2 (KLF2) and KLF4 and induces an accumulation of Vascular Endothelial Growth Factor Receptor (VEGFR) with the consequent promotion of tumor proliferation and angiogenesis. The gene discussed is KLF2; the disease is neoplasm.